Search research articles
Contact Us
Filters
Showing results (101-110 of 121) with videos related to
Page
of 13
Sort By:
Acta Haematologica
|
April 2, 2005
Non-Hodgkin's lymphomas in Greece according to the WHO classification of lymphoid neoplasms. A retrospective analysis of 810 cases
T Economopoulos, S Papageorgiou, M A Dimopoulos, et al.
Oncology
|
June 6, 2000
Anthracycline-based chemotherapy of primary non-Hodgkin's lymphoma of the testis: the hellenic cooperative oncology group experience
D Pectasides, T Economopoulos, G Kouvatseas, et al.
British Journal of Cancer
|
August 26, 2010
Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer
M Ihnen, R M Wirtz, K T Kalogeras, et al.
Anti-Cancer Drugs
|
January 19, 2005
Treatment of non-small cell lung cancer with gefitinib ('Iressa', ZD1839): the Greek experience with a compassionate-use program
E Razis, D Skarlos, E Briasoulis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 8, 2011
Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) Study
A Psyrri, K T Kalogeras, R Kronenwett, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 2010
Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG)
P A Kosmidis, G Fountzilas, A G Eleftheraki, et al.
Cancer Chemotherapy and Pharmacology
|
October 26, 2012
Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial
K Pliarchopoulou, K T Kalogeras, R Kronenwett, et al.
Breast Cancer Research and Treatment
|
May 20, 2011
Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer
E Razis, M Bobos, V Kotoula, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 2003
Docetaxel and cisplatin with granulocyte colony-stimulating factor (G-CSF) versus MVAC with G-CSF in advanced urothelial carcinoma: a multicenter, randomized, phase III study from the Hellenic Cooperative Oncology Group
A Bamias, G Aravantinos, C Deliveliotis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 28, 2005
Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study
H P Kalofonos, G Aravantinos, P Kosmidis, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 121) with videos related to
Sort By:
Page
of 13
Acta Haematologica
|
April 2, 2005
Non-Hodgkin's lymphomas in Greece according to the WHO classification of lymphoid neoplasms. A retrospective analysis of 810 cases
T Economopoulos, S Papageorgiou, M A Dimopoulos, et al.
Oncology
|
June 6, 2000
Anthracycline-based chemotherapy of primary non-Hodgkin's lymphoma of the testis: the hellenic cooperative oncology group experience
D Pectasides, T Economopoulos, G Kouvatseas, et al.
British Journal of Cancer
|
August 26, 2010
Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer
M Ihnen, R M Wirtz, K T Kalogeras, et al.
Anti-Cancer Drugs
|
January 19, 2005
Treatment of non-small cell lung cancer with gefitinib ('Iressa', ZD1839): the Greek experience with a compassionate-use program
E Razis, D Skarlos, E Briasoulis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 8, 2011
Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) Study
A Psyrri, K T Kalogeras, R Kronenwett, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 2010
Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG)
P A Kosmidis, G Fountzilas, A G Eleftheraki, et al.
Cancer Chemotherapy and Pharmacology
|
October 26, 2012
Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial
K Pliarchopoulou, K T Kalogeras, R Kronenwett, et al.
Breast Cancer Research and Treatment
|
May 20, 2011
Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer
E Razis, M Bobos, V Kotoula, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 2003
Docetaxel and cisplatin with granulocyte colony-stimulating factor (G-CSF) versus MVAC with G-CSF in advanced urothelial carcinoma: a multicenter, randomized, phase III study from the Hellenic Cooperative Oncology Group
A Bamias, G Aravantinos, C Deliveliotis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 28, 2005
Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study
H P Kalofonos, G Aravantinos, P Kosmidis, et al.
Page
of 13